Key result
Red cell distribution width was evaluated as a potential screening marker for right ventricular dysfunction in patients with stable chronic obstructive pulmonary disease.
Why the study?
Right ventricular dysfunction is a commonly overlooked yet prognostically important complication of COPD, and the role of RDW as a potential screening marker needed evaluation.
Does red cell distribution width (RDW) serve as a screening marker for right ventricular dysfunction in stable COPD patients?
Does red cell distribution width (RDW) serve as a screening marker for right ventricular dysfunction in stable COPD patients?
This study evaluates the potential of red cell distribution width as a simple blood biomarker to screen for right ventricular dysfunction in patients with stable COPD.
RDW may aid screening for RV dysfunction in stable COPD; leaves open need for prospective validation before clinical use.
objective. Right ventricular (RV) dysfunction is a commonly overlooked; but prognostically important complication of chronic obstructive pulmonary disease (copd). Red cell distribution width (RdW) is a potential blood parameter that may have a role in the detection of RV dysfunction. The present study was conducted to evaluate the role of RDW as a screening marker for RV dysfunction in copd.
No takes yet. Share an insight, caveat, or question.
Janmeja et al. (2022) studied this question. Red cell distribution width was evaluated as a potential screening marker for right ventricular dysfunction in patients with stable chronic obstructive pulmonary disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: